NCT01890733

Brief Summary

This is a post-marketing study to further assess the safety and effectiveness of the InSpace™ device implantation in comparison to surgical repair of full thickness Massive Rotator Cuff Tear . The effectiveness will be assessed by comparing the scores of the ASES, Constant and Quick DASH outcome questionnaires with respect to pain reduction, improvement of activity of daily living(ADL) and improvement of range of motion (ROM).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 2, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

June 4, 2020

Status Verified

September 1, 2012

Enrollment Period

2 years

First QC Date

June 27, 2013

Last Update Submit

June 3, 2020

Conditions

Keywords

Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,

Outcome Measures

Primary Outcomes (1)

  • Comparison of respose rate at each treatment arm

    The primary efficacy outcome of the study is considered as the subject response/rehabilitation rate at 6 month post implantation as assesed by the change in the Shoulder Score

    6m

Secondary Outcomes (2)

  • subjects requiring re-operation of the repaired tear at the end of the follow-up period.

    24 m post implantation

  • change of total questionnaires scores from baseline to each follow-up visit.

    6W, 3m, 6m , 12m ,24m

Study Arms (2)

Best Repair of torn Rotator Cuff

SHAM COMPARATOR

Subjects will undergo surgical intervention (usually arthroscopy) to perform debridment, acromioplasty if deemed necessary, long head of biceps tenotomy, and at least partial repair.

Device: Best Repair of torn Rotator Cuff

InSpace™ system

ACTIVE COMPARATOR

Subjects will undergo surgical intervention (usually arthroscopy or mini invasive) of debridment, acromioplasty if deemed necessary with or without long head of biceps tenotomy, and placement of the InSpace™ system.

Device: InSpace™ system

Interventions

Best Repair of torn Rotator Cuff
InSpace™ system

Eligibility Criteria

Age40 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40 or older.
  • Positive diagnostic imaging (CT arthrogram or MRI)\* of the affected shoulder indicating full thickness Massive RCT of at least 5cm in diameter (according to Cofield classification) or long - narrow tears of at least 4cm2 (W\>2cm and L\>2cm) including fatty infiltration grade III or IV (according to classification of Goutallier) involving more than one tendon. - Persistent pain and functional disability of the affected shoulder for at least 3 months.

You may not qualify if:

  • Known allergy to the balloon material (copolymer of PLA and -θ-caprolactone).
  • Evidence of significant osteoarthritis or cartilage damage in the shoulder
  • Evidence of gleno-humeral instability
  • Previous surgery of the shoulder in the past 2 years, excluding diagnostic arthroscopy
  • Evidence of major joint trauma, infection, or necrosis in the shoulder
  • Partial-thickness tears of the rotator cuff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico

Milan, Italy

Location

Study Officials

  • Luigi Solimeno, MD

    Policlinico de Milano

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2013

First Posted

July 2, 2013

Study Start

September 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2015

Last Updated

June 4, 2020

Record last verified: 2012-09

Locations